Keywords: mrsa, study, favor, pharmacia, zyvox, new, uk
MRSA study in favor of Pharmacia's Zyvox
Article | 24 June 2002
A new study in the UK of patients with presumed methicillin-resistantStaphylcoccus aureus infections has proved that treatment with Pharmacia's Zyvox ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
